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Abstract
Background: Members of the ribonuclease III superfamily of double-stranded(ds)-RNA-specific
endoribonucleases participate in diverse RNA maturation and decay pathways in eukaryotic and
prokaryotic cells. A human RNase III orthologue has been implicated in ribosomal RNA maturation.
To better understand the structure and mechanism of mammalian RNase III and its involvement in
RNA metabolism we determined the cDNA structure, chromosomal location, and expression
patterns of mouse RNase III.
Results: The predicted mouse RNase III polypeptide contains 1373 amino acids (~160 kDa). The
polypeptide exhibits a single C-terminal dsRNA-binding motif (dsRBM), tandem catalytic domains,
a proline-rich region (PRR) and an RS domain. Northern analysis and RT-PCR reveal that the
transcript (4487 nt) is expressed in all tissues examined, including extraembryonic tissues and the
midgestation embryo. Northern analysis indicates the presence of an additional, shorter form of
the transcript in testicular tissue. Fluorescent in situ hybridization demonstrates that the mouse
RNase III gene maps to chromosome 15, region B, and that the human RNase III gene maps to a
syntenic location on chromosome 5p13-p14.
Conclusions: The broad transcript expression pattern indicates a conserved cellular role(s) for
mouse RNase III. The putative polypeptide is highly similar to human RNase III (99% amino acid
sequence identity for the two catalytic domains and dsRBM), but is distinct from other eukaryotic
orthologues, including Dicer, which is involved in RNA interference. The mouse RNase III gene has
a chromosomal location distinct from the Dicer gene.
Background
The enzymatic cleavage of double-stranded(ds) RNA
structures is an essential step in the maturation and decay
of many eukaryotic and prokaryotic RNAs. Members of
the ribonuclease III superfamily of endoribonucleases [1]
are the primary agents of dsRNA cleavage [2]. RNase III or-
thologues are conserved in eukaryotes and in bacteria,
with Escherichia coli RNase III [3] as the best characterized
member. E. coli RNase III is active as a homodimer, and re-
quires a divalent metal ion (preferably Mg2+) to hydrolyze
phosphodiesters, creating 5'-phosphate, 3'-hydroxyl
product termini [4]. E. coli RNase III cleaves rRNA and
mRNA precursors as part of the respective maturation
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pathways. E. coli RNase III also initiates mRNA degrada-
tion, and participates in antisense RNA action [2,5–8].
Bacterial RNase III orthologues exhibit the simplest pri-
mary structure, which includes a C-terminal dsRNA-bind-
ing motif (dsRBM), and an N-terminal catalytic
(nuclease) domain (Figure 1). The dsRBM is present in
many other proteins that bind dsRNA [9,10] and is impor-
tant for RNase III activity in in vitro [11]. The catalytic do-
main contains a number of conserved residues, including
an 11 amino acid signature motif that is a distinguishing
feature of RNase III orthologues. The isolated E. coli RNase
III catalytic domain, which retains homodimeric behav-
ior, can cleave dsRNA substrates under specific conditions
in vitro [11]. The recently reported crystal structure of the
catalytic domain of Aquifex aeolicus RNase III reveals an ex-
tensive subunit interface, with the cleft between the subu-
nits predicted to bind dsRNA [12]. The two proposed
active sites are positioned at each end of the intersubunit
cleft and contain conserved residues from each subunit.
Several highly conserved carboxylic acids in the active
sites bind a single divalent metal ion [12], and one of
these residues has been shown to be essential for catalytic
activity of E. coli RNase III [13].
Two mammalian RNase III orthologues have been identi-
fied, and exhibit common domains as well as apparently
unique features. The RNase III orthologue "Dicer" (Figure
1) plays a central role in RNA interference (RNAi) by
cleaving dsRNAs to ~21 bp fragments, termed small inter-
fering(si) RNAs. The siRNAs are incorporated into a mac-
romolecular complex which carries out degradation of
Figure 1
Ribonuclease III superfamily members. The orthologues include bacteria, yeast, C. elegans, Drosophila, mammalian RNase III, and
mammalian Dicer. The textured boxes in the linear diagrams of the orthologues indicate the characteristic domain elements.
Mammalian RNase III
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Bacterial RNase III
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homologous RNA sequences [14]. Dicer action serves to
inhibit viral infection and retroposon movement, and
also plays a role in developmental pathways by cleaving
precursors to small regulatory RNAs (reviewed in
[14,15]). The predicted sequence of the mouse Dicer
polypeptide exhibits a single dsRBM and tandem catalytic
domains. In addition, the N-terminal region contains a
DExH/DEAH RNA helicase motif and a PAZ (Pinwheel-
Argonaut-Zwille) domain, which is also present in other
proteins involved in RNAi [16,17].
The second mammalian RNase III orthologue also exhib-
its a single C-terminal dsRBM and tandem catalytic do-
mains, but is otherwise structurally distinct from Dicer as
it lacks the helicase and PAZ domains (Figure 1) [18,19].
Preliminary evidence indicates that this RNase III ortho-
logue participates in rRNA maturation. Thus, a reduction
in human RNase III levels in vivo causes the accumulation
of specific rRNA processing intermediates [18]. Consistent
with this functional role, human RNase III localizes to the
nucleolus in a cell-cycle-dependent manner [18]. A trun-
cated form of human RNase III has been purified and
shown to cleave dsRNA in vitro [18]. However, little else is
known of the functional roles or the mechanistic features
of this enzyme. We report here (i) the characteristics of the
cDNA sequence and predicted polypeptide of mouse
RNase III, (ii) demonstrate transcript expression patterns,
and (iii) report the chromosomal locations of the mouse
and human RNase III genes.
Results and Discussion
Features of the mouse RNase III cDNA sequence
The mouse RNase III cDNA structure was determined by
sequence analysis of individual cDNA clones (see Materi-
als and Methods), whose sequences relative to the full-
length sequence are shown in Figure 2. The length of the
mouse RNase III cDNA is 4487 nt (see Additional File 1),
and the predicted initiation codon is at position 243. This
prediction is based on the occurrence of three in-frame
stop codons upstream of the indicated ATG, within the
242 nt 5'-untranslated region (5'-UTR) (see Additional
File 1). It is not firmly established if the reported 5' end
nucleotide corresponds to the true 5' end of the mRNA.
However, several independent partial cDNA clones (see
Figure 2) contain the same 5' nucleotide. There is no sig-
nificant sequence similarity of the mouse 5'-UTR with that
of human RNase III (245 nt). The 3'-UTR is 123 nt in size,
and contains a consensus polyadenylation signal
(AAUAAA) 12 nucleotides from the poly(A) tail. The 3'-
UTR exhibits 87% identity with the human 3'-UTR (372
nt) over a ~76 nt region, corresponding to positions 37–
113 of the mouse 3'-UTR and positions 39–115 of the hu-
man 3'-UTR. A search of the NCBI mouse EST database
yielded five independent clones which exhibit 100 per-
cent sequence identity with the 3'-UTR (data not shown).
The predicted 3'-UTR of the mouse RNase III mRNA and
that of the rat RNase III mRNA share 85% nucleotide
identity, and have the same lengths (data not shown).
Features of the predicted RNase III polypeptide
The dsRBM and catalytic domains
Conceptual translation of the mouse RNase III cDNA, us-
ing the AUG at position 243 as the initiation codon, yields
a polypeptide of 1373 amino acids with a predicted mo-
lecular mass of 158.8 kDa and a pI of 7.99. The polypep-
tide contains a single dsRBM and two RNase III catalytic
domain elements (see Additional File 1). The RNase III
domain (i.e. the two catalytic domains and dsRBM) of the
mouse and human sequences exhibit 99% amino acid
identity and 88% nucleotide sequence identity. Figure 3
provides an alignment of the RNase III domains of the
mouse, human, Drosophila and C. elegans RNase III ortho-
logues. The latter two sequences also exhibit strong con-
servation of sequence over the entire length of the region.
Note also that Drosophila RNase III has a serine-rich C-ter-
minal extension [19]. There are two catalytic domain sig-
nature sequences present in these orthologues. The single
signature sequence of bacterial RNase III orthologues not
only provides residues essential for catalysis, but contrib-
utes to the subunit interface [12]. It is therefore likely that
mouse RNase III is active as a homodimer. If so, the
holoenzyme may contain four active sites.
The Proline-rich region
A proline-rich region (PRR) is present in the N-terminal
portion of the polypeptide (see Additional File 1). Of the
63 prolines occurring in the PRR, 62 (98%) are conserved
in the corresponding region of human RNase III. Repeti-
tive proline sequences tend to adopt a polyproline II
(PPII) helix, consisting of an extended structure with three
residues per turn. A proline at every third position serves
to stabilize the structure [20], and also participates in hy-
drogen bonds as well as in hydrophobic interactions [21].
The presence of a PRR in mouse RNase III suggests pro-
tein-protein interactions important for function. PRR-me-
diated interactions are relatively weak and reversible, and
occur with the PPII helix in the C-terminal domain of
RNA polymerase II during transcription initiation and
elongation [22].
The Arginine/Serine (RS) domain
The mouse RNase III polypeptide contains an RS domain
adjacent to the PRR (see Additional File 1). The 13 posi-
tions containing the RS/SR dipeptide motif are shared be-
tween the mouse and human polypeptides, with an
overall 87% sequence identity, with the human sequence
containing an additional SR dipeptide. RS domains partic-
ipate in protein-protein interactions, and RS domain-con-
taining proteins play essential roles in constitutive or
alternative mRNA splicing [23–25]. RS proteins bind RNA
BMC Genomics 2002, 3 http://www.biomedcentral.com/1471-2164/3/26
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via an RNA recognition motif (RRM), allowing subse-
quent recruitment of splicing components via RS domain
interactions. The presence of this domain in mouse RNase
III suggests similar protein-protein interactions involved
in RNA maturation, which may be functionally associated
with components of the RNA splicing and transport ma-
chinery.
Potential sites of post-translational modification
Psort analysis of the predicted mouse RNase III amino
acid sequence indicates three potential nuclear localiza-
tion signals positioned at residues 254, 355 and 508 (see
Additional File 1). A Prosite scan identified multiple po-
tential phosphorylation sites for protein kinase C, casein
kinase II and cAMP-dependent protein kinase (data not
shown). Some of these signals may be involved in protein
localization, as it has been shown that human RNase III
localizes to the nucleolus during the cell cycle S phase
[18].
Figure 2
Positions of partial cDNA clones used to determine the complete cDNA sequence of mouse RNase III. The full-length cDNA
is represented by the shaded bar at the top, with specific domains indicated, and the 5' and 3' UTRs marked by the hashed
lines. The cDNA clones are identified by their accession numbers. The cDNA clone generated in-house from kidney cDNA is
represented by a solid black line and is labeled "cDNA clone" (GenBank Accession #AF533013). The dotted line indicates the
internal sequence missing from the clone. The Not1 restriction site is indicated by the asterisk and is the site of plasmid ligation
for a number of the cDNA clones. That there is no missing sequence at this position is indicated by (i) the continuity of the
open reading frame across this site, and (ii) an exact, continuous alignment with the human sequence across this site [18].
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Figure 3
Similarities of the RNase III domain (catalytic domains + dsRBM) of the human, mouse, Drosophila and C. elegans RNase III
orthologues. Multiple amino acid sequence alignment was performed using the CLUSTALW and Align programs. For the
mouse orthologue, the first amino acid shown corresponds to amino acid 892 in the complete sequence (see Additional File 1).
Blue: acidic residues; Pink, basic residues; Green, hydrophilic residues; Red, hydrophobic residues. The symbols below the
sequence refer to level of conservation: asterisk, completely conserved; colon and period: decreasing levels of conservation.
Human LLQLAMTHPSHHLNFGMNPDHARNSLSNCGIRQPKYGDRKVHHMHMRKKGINTLINIMSR 60
Mouse LLQLAMTHPSHHLNFGMNPDHARNSLSNCGIRQPKYGDRKVHHMHMRKKGINTLINIMSR 60
Drosophila LLQLALTHPSYKENYGTNPDHARNSLTNCGIRQPEYGDRKIHYMNTRKRGINTLVSIMSR 60
C.elegans VIELALMHSSFKSHYGTPIDHVKNMITNCGYRR-KYG-AEDKREKKRVAGIMSLFNIMKG 58
:::**: *.*.: ::* **.:* ::*** *: :** : : : * ** :*..**.
Human LGQDDPTPSRINHNERLEFLGDAVVEFLTSVHLYYLFPSLEEGGLATYRTAIVQNQHLAM 120
Mouse LGQDDPTPSRINHNERLEFLGDAVVEFLTSVHLYYLFPSLEEGGLATYRTAIVQNQHLAM 120
Drosophila FGKEHETVSNITHNERLEFLGDAVVEFLSSIHLFFMFPELEEGGLATYRAAIVQNQHLAL 120
C.elegans TSGGEP----ILHNERLEYLGDAVVELIVSHHLYFMLTHHFEGGLATYRTALVQNRNLAT 114
. . * ******:*******:: * **::::. ********:*:***::**
Human LAKKLELDPFMLYAHGPDLCRESDLRHAMANCFEALIGAVYLEGSLEEAKQLFGRLLFN- 179
Mouse LAKKLELDRFMLYAHGPDLCRESDLRHAMANCFEALIGAVYLEGSLEEAKQLFGRLLFN- 179
Drosophila LAKKLQLEEFMLYAHGSDLCHELELRHAMANCFEALMGALLLDGGIKVADEVFTDALFRQ 180
C.elegans LAKNCRIDEMLQYSHGADLINVAEFKHALANAFEAVMAAIYLDGGLAPCDVIFSKAMYGH 174
***: .:: :: *:**.** . :::**:**.***::.*: *:*.: .. :* ::
Human DPDLREVWLNYPLHPLQLQEPNTDRQLIETSPVLQKLTEFEEAIGVIFTHVRLLARAFTL 239
Mouse DPDLREVWLNYPLHPLQLQEPNTDRQLIETSPVLQKLTEFEEAIGVIFTHVRLLARAFTL 239
Drosophila DEKLLSIWKNLPEHPLQEQEPLGDRSCIDSYRVLKELTKFEDSIGIKFKHIRLLARAFTD 240
C.elegans QPVLKEKWDHINEHELKREDPQGDRDLSFITPTLSTFHALEERLGIQFNNIRLLAKAFTR 234
: * . * : * *: ::* **. .*. : :*: :*: *.::****:***
Human RTVGFNHLTLGHNQRMEFLGDSIMQLVATEYLFIHFPDHHEGHLTLLRSSLVNNRTQAKV 299
Mouse RTVGFNHLTLGHNQRMEFLGDSIMQLVATEYLFIHFPDHHEGHLTLLRSSLVNNRTQAKV 299
Drosophila RSIGFTHLTLGSNQRLEFLGDTVLQLICSEYLYRHFPEHHEGHLSLLRSSLVNNRTQAVV 300
C.elegans RNIPNNDLTKGHNQRLEWLGDSVLQLIVSDFLYRRFPYHHEGHMSLLRTSLVSNQTQAVV 294
*.: ..** * ***:*:***:::**: :::*: :** *****::***:***.*:*** *
Human AEELGMQEYAITNDKTKRPVALRTKTLADLLESFIAALYTDKDLEYVHTFMNVCFFPRLK 359
Mouse AEELGMQEYAITNDKTKRPVALRTKTLADLLESFIAALYIDKDLEYVHTFMNVCFFPRLK 359
Drosophila CDDLGMPKYAVYANP---KADLKTKDRADLLEAFLGALYVDKGLLYCEQFCHVCLFPRLQ 357
C.elegans CDDLGFTEFVIKAPY--KTPELKLKDKADLVEAFIGALYVDRGIEHCRAFIRIVFCPRLK 352
.::**: ::.: *: * ***:*:*:.*** *:.: : . * .: : ***:
Human EFILNQDWNDPKSQLQQCCLTLRTE-GKEPDIPLYKTLQTVGPSHARTYTVAVYFKGERI 418
Mouse EFILNQDWNDPKSQLQQCCLTLRTE-GKEPDIPLYKTLQTVGPSHARTYTVAVYFKGERI 418
Drosophila LFIMNQDWNDPKSKLQQCCLTLRTMDGGEPDIPYYKVVEASGPTNTRVYKVAVYFRSKRL 417
C.elegans HFIESEKWNDAKSHLQQWCLAMRDPSSSEPDMPEYRVLGIEGPTNNRIFKIAVYYKGKRL 412
** .:.***.**:*** **::* . ***:* *:.: **:: * :.:***::.:*:
Human GCGKGPSIQQAEMGAAMDALEKYN---FPQMAHQKRFIERKYRQELK---EMRWEREHQE 472
Mouse GCGKGPSIQQAEMGAAMDALEKYN---FPQMAHQKRFIERKYRQELK---EMRWEREHQE 472
Drosophila ATSSGSSIQQAEMNAAKQALENSRDL-FPQLDHQKRVIAKSIKKQTGNELDNDSDRQHQE 476
C.elegans ASAAESNVHKAELRVAELALANLESMSFSKMKAKNNSWFQNMRRRLE------------- 459
. . ..:::**: .* ** : . *.:: ::. :. ::.
Human R------------------------------EPDETEDIKK------------------- 483
Mouse R------------------------------EPEEAEDIKK------------------- 483
Drosophila EKIKRPKYATPLQDESHLPKQYRMHENISSDELPEDEDFESTAPKSPTMPLRSNRSGSSS 536
C.elegans ---------------------------------QDTSD---------------------- 464
: .*
Human ---------------------------------
Mouse ---------------------------------
Drosophila SSSSSDSDGSTSSPKCKRRLKKCSSVSSKSSLG 569
C.elegans ---------------------------------
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Mouse RNase III transcript expression patterns
The transcript expression patterns were analyzed by RT-
PCR and by northern blot (Figures 4A,4B). The analyses
show that the mouse RNase III transcript is expressed in
all adult organs examined, as well as in the E13.5 midges-
tation embryo, the extraembryonic yolk sac, and the pla-
centa. Northern analysis (Figure 4B) reveals a transcript
size of ~4.5 kb, which is consistent with the predicted
length of the cDNA, including a poly(A) tail. The northern
analysis also reveals that the transcript is heavily expressed
in brain tissue and perhaps also heart tissue, while only
lightly expressed in skeletal muscle. The reason(s) for the
differential levels of expression is unclear, but it is of inter-
est to note that the mouse Dicer transcript is also promi-
nently expressed in brain and heart tissue, while only
lightly expressed in skeletal muscle [17]. Interestingly, an
Figure 4
Expression analysis of the mouse RNase III transcript. A. RT-PCR analysis of the RNase III transcript in adult mouse organs, in
day 13.5 (E13.5) mouse embryo ("Embryo"), and in extra-embryonic organs ("Placenta" and "Yolk Sac"). Analysis was per-
formed as described in Materials and Methods. The 272 bp PCR product was generated using an oligodeoxynucleotide pair that
localized to a sequence in the dsRBM (forward primer) and 3'-UTR (reverse primer). For each lane, a separate RT-PCR analysis
which omitted reverse transcriptase did not provide a DNA product (data not shown). The lower panel displays a control
experiment showing uniform production of a β-actin mRNA-specific PCR product (100 bp). DNA size markers are provided in
lane M. B. Northern analysis of the RNase III transcript. A 32P-labeled, 1.2 kb probe specific to the 3' region of the RNase III
sequence (cDNA clone accession no. AA549506) was hybridized to a multiple tissue northern blot. Each lane contained 2 µg of
poly(A)+ RNA from the indicated adult mouse organs (upper panel). The blot was visualized by phosphorimaging. The actin
control blot is shown in the lower panel. The 1.8 kb transcript in the heart, skeletal muscle and testis lanes represents an alter-
natively processed actin RNA.
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additional species (~3.5 kb) is present in testis (Figure
4B), which may represent an alternatively processed form
of the transcript. This species is not seen in the testis lane
of the RT-PCR analysis, since the PCR primers are targeted
to the 3'-UTR, which is most likely the same for the two
transcripts.
Chromosomal locations of the mouse and human ribonu-
clease III genes
The mouse RNase III gene was mapped using fluorescent
in situ hybridization (FISH), employing a partial cDNA
clone as probe. The gene is located in the proximal seg-
ment (region B) of chromosome 15 (Figure 5A). The hu-
man ribonuclease III gene was mapped to chromosome
5p13-p14 (Figure 5B), a region that is syntenic to mouse
chromosome 15B.
Conclusions
Sequence database searches and other studies [17] have
revealed only two RNase III orthologues (Dicer and RNase
III) in the mouse and human genomes. However, the
presence of an additional RNase III-specific transcript in at
least one tissue indicates the possibility of alternative
forms of RNase III. The broad expression pattern suggests
a conserved cellular function for mouse RNase III. In this
regard, sequence database searches and a southern "zoo"
blot (data not shown) indicate significant conservation of
the RNase III gene among many other vertebrates, includ-
ing rat, rabbit and cow. However, functional roles for
mammalian RNase III have yet to be fully defined. A role
in rRNA maturation is suggested by the observation that
antisense oligodeoxynucleotide-mediated reduction in
human RNase III levels also causes a decrease in the
Figure 5
Chromosomal locations of the mouse and human RNase III genes. Fluorescent in situ hybridization (FISH) analysis was per-
formed according to published procedures [36,37] by SeeDNA Biotech, Inc. (Windsor, Ontario, Canada). The mouse gene
mapping result is shown in panel A, and the human gene mapping result shown in panel C. For the mouse gene mapping exper-
iment, the probe was a mouse cDNA clone (Accession No. AA549506; ~1.2 kb insert). For the human gene mapping experi-
ment, the probe was a human cDNA clone (Accession No. AA460045; 1.26 kb insert).
Human RNase III
5p13-14
Mouse RNase III
15B
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amount of 5.8 S rRNA and a concomitant increase in the
12 S precursor [18]. A similar defect in rRNA maturation
is seen upon U8 snoRNA depletion in Xenopus oocytes
[26]. As U8 snoRNA participates in rRNA maturation, it is
possible that an RNase III-dependent step also involves
U8 snoRNA. Alternatively, a role for RNase III in the mat-
uration of U8 snoRNA (as well as other snoRNAs) is a pos-
sibility. In this regard, the S. cerevisiae RNase III
orthologue Rnt1p not only cleaves the 35 S rRNA precur-
sor within the 3'-ETS [27–29], but also processes snoRNA
and snRNA precursors [30–33]. Further biochemical stud-
ies are required to identify the RNA targets for mammali-
an RNase III and to determine its involvement in RNA
maturation pathways.
Methods
Materials
Chemicals and reagents were molecular biology grade or
reagent grade and were purchased from Fisher Scientific or
Sigma Chemical Company. Restriction enzymes were pur-
chased from New England Biolabs and were used accord-
ing to the supplied instructions. The radiolabeled
nucleotide [α-32P]dCTP (3,000 Ci/mmol) and nick trans-
lation kits were purchased from Amersham-Pharmacia.
Oligodeoxynucleotides used for DNA sequencing and
PCR were synthesized by Invitrogen. The Multiple Tissue
Northern (MTN) blot was obtained from Clontech.
I.M.A.G.E. Consortium cDNA clones were obtained from
Invitrogen/Research Genetics. The cDNA used as template
for PCR cloning and sequencing was obtained from Clon-
tech (Marathon-Ready cDNA), or prepared from mouse
liver or kidney RNA as previously described [34]. Bacterial
plasmids used in DNA sequencing reactions were purified
using Qiagen plasmid purification kits. DNA sequencing
reactions employed an ABI 3700 automated DNA Analyz-
er, and Big Dye terminator kits. Sequences were assem-
bled with the ABI DNA sequencing analysis software
(v3.6).
Determination of the mouse ribonuclease III cDNA se-
quence
Several avenues were followed to obtain the complete
cDNA sequence for mouse RNase III. One strategy was
based on a previous study [35] which identified eukaryo-
tic RNase III orthologues by a BLAST search of the NCBI
translated mouse EST database, using E. coli RNase III as
query sequence. We carried out a similar search against
the NCBI mouse EST database, using the Drosophila and
human RNase III [18,19] as query sequences. Specific
clones were identified, obtained and sequenced. The
clone positions and accession numbers are given in Figure
2.
In a second approach, mouse kidney cDNA (Clontech
Marathon-ready cDNA) served as a template for PCR
which used the Advantage-2 Polymerase Mix (Clontech).
The PCR reaction (50 µl volume) also included: 10 µM
each primer (sequences available by request), and 5 µl of
the cDNA preparation. The PCR conditions were: 94° for
30 sec, then 5 cycles of 94° (5 sec) and 72° (4 min.). This
was followed by 5 cycles of: 94° (5 sec) and 70° (4 min.).
The final steps consisted of 20–25 cycles of 94° (5 sec.)
and 68° (4 min.). The products were purified and cloned
into plasmid pPICZ-C (Invitrogen) at the SfiI and SnaB1
sites. The recombinant clone (indicated in Figure 2) was
sequenced (Accession Number AF533013). All sequences
obtained as described above were subjected to a series of
CLUSTALW alignments. Additional clone sequences ob-
tained from the NCBI database were used for further veri-
fication of the assembled sequence. The assembled cDNA
sequence was subjected to hypothetical translation using
the "Translate" program available on the EXPASY website
[www.expasy.ch]. Functional domains were determined
using CLUSTALW and manual methods. The molecular
weight was calculated using the primary structure analysis
program available from ExPASY proteomics tools. Poten-
tial post-translational modification sites and nuclear lo-
calization signals were identified using PROSITE and
Psort programs, respectively  [www.expasy.ch].
Expression analyses
Total RNA was obtained from mouse embryonic tissue or
adult mouse organs and reverse transcription carried out
as described [34]. For each tissue analysis, PCR was carried
out in a 25 µl reaction volume using 1 µl of the first-strand
cDNA reaction, according to the Superscript Preamplifica-
tion System for First Strand cDNA Synthesis (Invitrogen).
Primer sequences were (forward) 5'-GGGGCCATCCCAT-
GCTAGAA-3' and (reverse) 5'-CCACTCCTGCCCTCGTT-
TACT-3'. PCR conditions were 95°C × 10 min; 25 cycles of
94°C × 1 min; 55°C × 1 min; 72°C × 1 min; with a final
extension of 72°C × 5 min. β-actin was used as an internal
standard; primer sequences were (forward) 5'-
CCCAACTTGATGTATGAAGG-3' and (reverse) 5'-TTGTG-
TAAGGTAAGGTGTGC-3'. PCR conditions were 95°C × 1
min, 30 cycles of 94°C × 30 sec, 58°C × 30 sec, 72°C × 1
min, with a final extension of 72°C × 3 min. Reactions
were analyzed by electrophoresis in 1% agarose gels, and
DNA was visualized by ethidium staining.
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Mouse RNase III cDNA and amino acid sequences. The proposed trans-
lational initiation codon and the polyadenylation signal are underlined. 
The three in-frame stop codons upstream of the initiation codon are itali-
cized. Nucleotide and amino acid positions are provided on the right. The 
human RNase III amino acid sequence is also shown in italics. The shaded 
amino acids indicate residues in the Proline-rich region, the RS domain, 
and the catalytic domain signature sequences. Three potential nuclear lo-
calization signals beginning at positions 254, 355 and 508 are under-
lined.
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